Avanos Medical, Inc.

Healthcare

NYSE:AVNS · New York Stock Exchange

Market Cap $1.17B Beta 1.57 P/E (TTM) -16.7

$24.96 -0.08%

-$0.02 today

52W Low $9.30High $25.49

Vol 0.31M · Avg 1.51M

EPS (TTM)-$1.50

Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+106.28%

Period High

$25.05

Period Low

$9.89

Latest

$24.96

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

CeriBell, Inc.

NASDAQ:CBLL

$700.80M

Bioventus Inc.

NASDAQ:BVS

$576.54M

Cytek Biosciences, Inc.

NASDAQ:CTKB

$511.40M

Varex Imaging Corporation

NASDAQ:VREX

$464.78M

4D Molecular Therapeutics, Inc.

NASDAQ:FDMT

$461.60M

Community Health Systems, Inc.

NYSE:CYH

$439.66M

Pacific Biosciences of California, Inc.

NASDAQ:PACB

$406.89M

ClearPoint Neuro, Inc.

NASDAQ:CLPT

$403.06M

Standard BioTools Inc.

NASDAQ:LAB

$346.53M

Bicycle Therapeutics plc

NASDAQ:BCYC

$281.05M

What is the latest AVNS filing?

The latest filing shown is DEFM14A dated Jun 10, 2026.

How many recent filings does AVNS have?

Intrinsic Alpha currently shows 20 recent filings for AVNS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.